Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Loftis

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Psychoneuroendocrinology|July 2, 2013
Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptomsJennifer M Loftis
Frontiers in Microbiology|January 19, 2016
Commentary: Methamphetamine mediates immune dysregulation in a murine model of chronic viral infectionJennifer M Loftis
Brain, Behavior, and Immunity|December 9, 2023
Seeking understanding and action for the neurologic consequences of SARS-CoV-2 infectionJennifer M Loftis
Addiction (Abingdon, England)|March 9, 2011
Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addictionJennifer M Loftis, Marilyn Huckans
Digestive Diseases and Sciences|August 21, 2013
Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patientJennifer M Loftis, Peter Hauser
Pharmacology & Therapeutics|December 21, 2002
The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implicationsJennifer M Loftis, Aaron Janowsky
Human Psychopharmacology|March 31, 2005
Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'Jennifer M Loftis, Peter Hauser
Pharmacology, Biochemistry, and Behavior|May 13, 2022
A spotlight on HCV and SARS-CoV-2 co-infection and brain functionKate Shirley, Jennifer M Loftis
Journal of Affective Disorders|October 19, 2004
The phenomenology and treatment of interferon-induced depressionJennifer M Loftis, Peter Hauser
Psychopharmacology|November 29, 2002
Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunitJennifer M Loftis, Aaron Janowsky
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Psychoneuroendocrinology|July 2, 2013
Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptomsJennifer M Loftis
Frontiers in Microbiology|January 19, 2016
Commentary: Methamphetamine mediates immune dysregulation in a murine model of chronic viral infectionJennifer M Loftis
Brain, Behavior, and Immunity|December 9, 2023
Seeking understanding and action for the neurologic consequences of SARS-CoV-2 infectionJennifer M Loftis
Addiction (Abingdon, England)|March 9, 2011
Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addictionJennifer M Loftis, Marilyn Huckans
Digestive Diseases and Sciences|August 21, 2013
Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patientJennifer M Loftis, Peter Hauser
Pharmacology & Therapeutics|December 21, 2002
The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implicationsJennifer M Loftis, Aaron Janowsky
Human Psychopharmacology|March 31, 2005
Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'Jennifer M Loftis, Peter Hauser
Pharmacology, Biochemistry, and Behavior|May 13, 2022
A spotlight on HCV and SARS-CoV-2 co-infection and brain functionKate Shirley, Jennifer M Loftis
Journal of Affective Disorders|October 19, 2004
The phenomenology and treatment of interferon-induced depressionJennifer M Loftis, Peter Hauser
Psychopharmacology|November 29, 2002
Cocaine treatment- and withdrawal-induced alterations in the expression and serine phosphorylation of the NR1 NMDA receptor subunitJennifer M Loftis, Aaron Janowsky
Pageof 10